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This Delphi consensus by 28 experts from the European Association of Preventive Cardiology (EAPC) provides initial recommendations
on how cardiovascular rehabilitation (CR) facilities should modulate their activities in view of the ongoing coronavirus disease 2019
(COVID-19) pandemic. A total number of 150 statements were selected and graded by Likert scale [from -5 (strongly disagree) to þ5
(strongly agree)], starting from six open-ended questions on (i) referral criteria, (ii) optimal timing and setting, (iii) core components,
(iv) structure-based metrics, (v) process-based metrics, and (vi) quality indicators. Consensus was reached on 58 (39%) statements,
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48 ‘for’ and 10 ‘against’ respectively, mainly in the field of referral, core components, and structure of CR activities, in a
comprehensive way suitable for managing cardiac COVID-19 patients. Panelists oriented consensus towards maintaining usual activities on
traditional patient groups referred to CR, without significant downgrading of intervention in case of COVID-19 as a comorbidity.
Moreover, it has been suggested to consider COVID-19 patients as a referral group to CR per se when the viral disease is complicated
by acute cardiovascular (CV) events; in these patients, the potential development of COVID-related CV sequelae, as well as of pulmonary
arterial hypertension, needs to be focused. This framework might be used to orient organization and operational of CR programmes
during the COVID-19 crisis.
...................................................................................................................................................................................................
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Introduction
The coronavirus disease 2019 (COVID-19) pandemic poses
several questions to the cardiovascular rehabilitation (CR) com-
munity, both concerning the management of ‘usual’ cardiovascular
(CV) patients (often hampered by reduced referral and/or com-
plexity of acute events, due to delayed time-to-care), and the new
‘cardiac-COVID’ phenotype. This latter refers to CV patients suf-
fering from COVID-19, as well as to COVID-19 patients who de-
velop CV complications from the viral disease,1 in which
interventions are often empiric due to the novelty of the disease
and scant data on long-term prognosis.
From a socio-economic perspective,2 during Phase 1, infection
ran in absence of active management. Now—at various times in
affected Countries—the COVID-19 crisis is passing through Phase
2 (characterized by social distancing and shutdown of non-core
activities) and Phase 3 (i.e. the construction of pandemic manage-
ment protocols by all organizations in society), and finally will end
with the Phase 4, when a vaccine will become available for eradica-
tion and/or disease attenuation. During Phases 2 and 3, CR facilities
are asked to ‘deliver as much CR as possible’ in a situation charac-
terized by extraordinary measures to prevent the spread of the
disease and to organize dedicated clinical services, potentially lead-
ing to de-powering/closure of CR services and redeployment of
CR staff. Moreover, even in presence of full operation, there is a
need of consensus about modulation of CR activities at a local
level, with adjustment of process and outcome variables to the
COVID-19 era.
In view of this situation, an international panel of experts from
the Secondary Prevention and Rehabilitation Section of the
European Association of Preventive Cardiology (EAPC) partici-
pated in a Delphi process to identify consensus on CR activities
during COVID-19 pandemic, the results of which are provided in
this article.
Methods
The Delphi methodology3 uses a series of questionnaires to facilitate
consensus building among experts within certain topic areas. For the
purpose of our study, a rapid modified Delphi process (Figure 1) was
designed in three rounds of questionnaires: the first round focused
on preparation of open-ended questions to ensure comprehensive
inclusion of expert concepts; rounds 2 and 3 applied quantitative
assessments to identify consensus. Questionnaire 1 was developed
by M.A. and D.H., based on two recent EAPC source documents4,5
on ‘how to’ provide CR intervention, coupled with clinical
experience gained during the COVID-19 outbreak, and contained
the following six open-ended questions: (i) which are appropriate
referrals to CR in the COVID-19 era (by distinguishing CV disease
and COVID-19 as primary diagnosis)? (ii) Which are the optimal
timing and setting of CR in the COVID-19 era (by distinguishing
patients without and with history of COVID-19, respectively)?
(iii) Which are the core components of CR in the COVID-19 era
(by distinguishing patients without and with history of COVID-19,
respectively)? (iv) Which are minimal structure-based metrics for
CR programmes in the COVID-19 era? (v) Which are minimal
process-based metrics for CR programmes in the COVID-19 era?
(vi) Which quality indicators should be selected for CR programmes
in the COVID-19 era?
Delphi panelists with international recognition as experts in CR were
recruited—on a voluntary basis—within the EAPC Secondary
Prevention and Rehabilitation Section Nucleus 2018–2020,6 the
writing committees of the two EAPC source documents,4,5 the EAPC
Exercise Prescription in Everyday Practice and Rehabilitative Training
(EXPERT) tool study group,7 and among national experts from countries
more heavily affected by COVID-19 selected by the Nucleus.
The Questionnaire 2, containing 150 statements regarding different
options and practical approaches to the six open-ended questions (also
potentially diverging,), was licensed by the EAPC Secondary Prevention
and Rehabilitation Section Nucleus, and incorporated the qualitative con-
cepts from Questionnaire 1. Both Questionnaires 1 and 2 allowed on-
going opportunity for respondent commentary and clarification and were
open to modifications.
Panelists were asked to treat statements independently and to rate
their agreement with question statements using an 11-point Likert scale
from -5 (strongly disagree) toþ5 (strongly agree). Panelists had the pos-
sibility to skip certain statements, based on individual expertise and pro-
fessional profile. As in previous experience with the Delphi modified
method,8 consensus was defined a priori as either a mean Likert score
>_2.5 or <_ -2.5 signifying either consensus ‘for’ or ‘against’ the statement,
respectively, with standard deviation not crossing zero. Scores > -2.5 and
<2.5 indicate no consensus.
Questionnaire 3 contained items from Questionnaire 2, displayed with
the mean ± SD of the group’s response in Questionnaire 2, and panelist’s
prior response was asked to be confirmed or modified. Selected com-
ments were edited and incorporated anonymously in the statements and
questionnaires distributed to panelists in each round.
Data were analysed and reported by descriptive statistics.
Differences between panelists answers by countries as categorical var-
iables were tested using either the v2 or the Fisher’s exact test, when
appropriate.








A total of 28 experts from 12 countries (Austria, Belgium, France,
Germany, Greece, Italy, The Netherlands, Portugal, Romania, Russia,
Spain, and Switzerland) participated in the Delphi process. Roles in
the CR chart were as follows: programme director (n = 9; 32%), car-
diologist (n = 12; 43%), physiotherapist (n = 4; 14%), exercise physiol-
ogists (n = 2; 7%), and psychologist (n = 1; 4%). The majority of
them (93%) declared Phase II CR as the main area of work/interest,
while the distribution of the CR setting was as follows: residential
Figure 1 Modified Delphi process.






















































































..(n = 11; 39%), out-patient/ambulatory (n = 16; 57%), and home-
based/telerehabilitation (n = 1; 4%).
At the end of the Delphi process, consensus was reached on 58
(39%) statements, with 48 and 10 statements receiving consensus
‘for’ and ‘against’, respectively. Between round 2 and 3, new consen-
sus was found in 6 out of 31 statements for referrals, 3/44 for compo-
nents, and 2/21 for quality indicators, while all other statements were
confirmed. The complete results of the 2nd and 3rd round of the
Delphi process are detailed in Table 1.
Referrals to cardiovascular rehabilitation
Among patients with CV disease as primary diagnosis, panelists
reached consensus on continuing referral to CR—independently
from an eventual history of COVID-19—for the following major con-
ditions: post-acute coronary syndrome (ACS) and post-primary
angioplasty (4.22 ± 2.11), chronic coronary syndromes (3.14± 2.51),
coronary artery or valve heart surgery (3.91 ± 2.27), chronic heart
failure (3.96± 2.14), cardiac transplantation (3.09± 2.59), and pres-
ence of ventricular assist device (3.13 ± 2.96). Other conditions, such
as device implantation and peripheral artery disease, did not reach
consensus; however, consensus was reached on priorities with re-
gard to CV referral diagnoses to be defined at a local level (Hospital,
Institution, CR facility) (2.95± 2.85). When a history of COVID-19
was present in this patient population, neither previous invasive/non-
invasive ventilation nor other COVID-19 related conditions (i.e. pro-
longed stay in intensive care units, hypoxia, viral pneumonia, or re-
spiratory symptoms) constituted criteria for patient selection in the
referral process (Likers scale scores all <_ -3.0).
Among patients with COVID-19 as primary diagnosis, highest
degrees of consensus were reached on considering several acute
complicating CV events (angina pectoris, ACS, exacerbation of heart
failure, cardiogenic shock, myocarditis, arrhythmias, resuscitated sud-
den cardiac death, pericarditis/cardiac tamponade, and arterial/ven-
ous thromboembolic events) as appropriate referrals to CR
(3.68± 2.68), as well as the progressive developing of pulmonary ar-
terial hypertension (2.91 ± 2.45). Regardless of criteria for referral,
CR should take place only in documented COVID free patients
(namely, a single or double negative nasopharyngeal specimen for
COVID-19, depending on local policies).
Timing and setting of cardiovascular
rehabilitation
Regarding timing of CR, in CV patients without history of COVID-19,
no statement considering track variations to CR reached consensus,
while in primary COVID-19 patients there was orientation against
starting CR during the acute phase of the viral disease (-3.48± 2.44).
Other COVID-19 related features (such as radiologic recovery of
pneumonia or arterial blood gas parameters) were not necessarily
considered determinants for the timing to start CR.
In CV patients without history of COVID-19, the outpatient set-
ting was deemed as the preferred setting to avoid contacts with hos-
pitalized patients and health operators (2.87 ± 2.40), especially when
residential CR facilities are not separated from other wards.
Core components of cardiovascular
rehabilitation
In patients without history of COVID-19 there was no need to mod-
ify traditional core components of CR intervention, with the excep-
tion to provide specific education on COVID-19 within counselling
activities (3.43 ± 2.35).
In patients presenting with a history of COVID-19 the core com-
ponent ‘patient evaluation’ should always comprise patterns of re-
spiratory impairment (3.57± 2.50) and, in view of the often
multifactorial aetiology of exercise intolerance in these patients, car-
diopulmonary exercise testing (CPET) should always be per-
formed—when confirmed negative testing for COVID-19—at the
start of the CR programme (3.14± 2.46). The active search of frailty
(3.05 ± 2.80), as far as a detailed history of symptomatic or asymp-
tomatic COVID-19 among relatives and caregivers (3.00 ± 2.98),
should also be part of the recommended strategy for evaluating
patients during CR programmes. In healed-up COVID-19 patients,
strength training should also be included as normally indicated in CR
programmes (3.67± 1.96), especially in frail patients (4.10 ± 1.34),
while inspiratory muscle training (IMT) or other respiratory techni-
ques did not reach definite consensus ‘for’ or ‘against’. In any case,
whatever the selected exercise protocol, patients should maximize
non-structured physical activity at home on daily basis (3.76 ± 1.87).
The core component ‘diet/nutritional counselling’ should always be
particularly devoted to malnutrition as a consequence of prolonged
immobilization and ventilatory support (3.14± 2.46). The psycho-
social management in COVID-19 patients constituted the top area of
consensus for reinforced intervention on growing needs, such as
smoking cessation (3.27 ± 2.62), return to work (3.82 ± 1.65),
caregiver-limiting restrictive measures (2.82 ± 2.44), and fighting of
fake news (3.36± 2.26).
Structure-based metrics
There was consensus on modifying structure-based metrics in resi-
dential CR facilities, especially with respect to allocation of separate
areas to newly confirmed (3.61± 2.86) and suspected (3.52± 2.84)
COVID-19 cases, as well as to availability of adequate protection to
health operators and patients during aerosol-generating manoeuvres,
indoor exercise training, and all phases of the multidisciplinary staff
activity (details in Table 1). A particularly high consensus score was
reached (4.25 ± 1.36) on the recommendation to formally structure
contacts between patients and families in case of lockdown.
Process-based metrics
Among actions modulating the processes of CR facilities, there was
strong consensus (4.09 ± 1.38) on encouraging remote activities
(tele-rehabilitation, facilitated home-based, web-based, supervised
community-based, guided by digital health tools, etc.) that might inte-
grate or fully replace routine operational of residential and ambula-
tory CR facilities, according to different phases of COVID-19
pandemic. Special attention should also be payed to the transition to
primary care after the end of the programme, by identifying discharge
plans consistent with limitations related to the COVID-19 outbreak
(e.g. travel restrictions impeding lifestyle prescriptions or scheduled
examinations; 3.95 ± 1.40). As a practical suggestion, there was con-
sensus on providing a continuing help-desk to discharged patients




Table 1 Results of the Delphi Questionnaire
Round 1: Questionnaire development Round 2 Round 3
n Question Mean SD Intermediate
consensus
Mean SD Final
consensusn n n n
Open question: which are appropriate referrals to CR in the COVID-19 era?
1 Primary diagnosis:
CV disease
All patients with primary cardiovascular diagnosis of ‘post-ACS and post-primary PCI’
should be referred to CR, independently from the history of COVID-19
3.74 2.86 For 4.22 2.11 For (confirmed)
2 All patients with primary cardiovascular diagnosis of ‘chronic coronary syndromes’ should
be referred to CR, independently from the history of COVID-19
2.77 3.05 NC 3.14 2.51 For (new)
3 All patients with primary cardiovascular diagnosis of ‘coronary artery or valve heart sur-
gery’ should be referred to CR, independently from the history of COVID-19
3.41 2.95 For 3.91 2.27 For (confirmed)
4 All patients with primary cardiovascular diagnosis of ‘chronic heart failure’ should be
referred to CR, independently from the history of COVID-19
3.35 2.85 For 3.96 2.14 For (confirmed)
5 All patients with primary cardiovascular diagnosis of ‘cardiac transplantation’ should be
referred to CR, independently from the history of COVID-19
2.74 3.11 NC 3.09 2.59 For (new)
6 All patients with primary cardiovascular diagnosis of ‘device implantation’ should be
referred to CR, independently from the history of COVID-19
2.14 3.43 NC 2.64 3.09 NC
7 All patients with primary cardiovascular diagnosis of ‘presence of ventricular assist device’
should be referred to CR, independently from the history of COVID-19
2.48 3.60 NC 3.13 2.96 For (new)
8 All patients with primary cardiovascular diagnosis of ‘peripheral artery disease’ should be
referred to CR, independently from the history of COVID-19
2.04 3.15 NC 2.57 2.86 NC
9 Only patients with ischaemic heart disease as primary cardiovascular qualifying diagnosis
to CR should be referred to CR, independently from the history of COVID-19
-2.26 3.60 NC -2.26 3.60 NC
10 Patients with CHF should not be referred’ as referral of this group (i.e. the exercise pro-
gramme) is more controversial due to the high risk of centre-based CR and safety con-
cerns of telerehabilitation
-1.73 3.79 NC -2.09 3.49 NC
11 Aged/frail patients should not be referred’ as referral of this group (i.e. the exercise pro-
gramme) is more controversial due to the high risk of centre-based CR and safety con-
cerns of telerehabilitation
-0.82 3.74 NC -1.09 3.45 NC
12 Priorities on which primary cardiovascular qualifying diagnosis should be referred to CR,
independently from the history of COVID-19, should be defined at a local level
(Hospital/Institution/CR facility)
2.77 3.04 NC 2.95 2.85 For (new)
13 Only patients with a primary cardiovascular qualifying diagnosis to CR and a history of
COVID-19 should be referred to CR
-2.04 4.19 NC -2.39 3.90 NC
14 CV patients referred to CR should have no history of COVID-19 -2.39 3.07 NC -2.74 2.61 Against (new)
15 Patients referred with a primary qualifying diagnosis for CR and a history of COVID-19
are limited to those having experienced invasive ventilation


















Round 1: Questionnaire development Round 2 Round 3
n Question Mean SD Intermediate
consensus
Mean SD Final
consensusn n n n
16 Patients referred with a primary qualifying diagnosis for CR and a history of COVID-19
are limited to those having experienced non-invasive ventilation
-3.26 2.78 Against -3.70 2.14 Against
(confirmed)
17 Patients referred with a primary qualifying diagnosis for CR and a history of COVID-19
are limited to those having experienced stay in ICUs
-2.96 3.05 NC -3.39 2.54 Against (new)
18 Patients referred with a primary qualifying diagnosis for CR and a history of COVID-19
are limited to those having experienced hypoxia
-3.35 2.69 Against -3.78 2.00 Against
(confirmed)
19 Patients referred with a primary qualifying diagnosis for CR and a history of COVID-19
are limited to those having experienced viral pneumonia
-3.70 2.12 Against -3.70 2.12 Against
(confirmed)
20 Patients referred with a primary qualifying diagnosis for CR and a history of COVID-19
are limited to those having experienced any kind of symptom
-3.00 2.91 Against -3.00 2.91 Against
(confirmed)
21 Patients referred with a primary qualifying diagnosis for CR and a history of COVID-19
are limited to those aged >75 and/or frail, whichever symptoms of COVID-19




COVID-19 patients should be referred to CR, independently from the history of CV
disease
-2.43 3.62 NC -2.78 3.23 NC
23 COVID-19 patients with pre-existing cardiovascular disease should be referred to CR 1.17 3.73 NC 1.09 3.65 NC
24 COVID-19 patients with multiple CV risk factors should be referred to CR 1.64 3.51 NC 1.55 3.45 NC
25 COVID-19 patients complicated by one or more adverse cardiac symptoms/events (an-
gina pectoris, ACS, exacerbation of heart failure, cardiogenic shock, myocarditis,
arrhythmias, resuscitated SCD, pericarditis/cardiac tamponade, and/or arterial/venous
thromboembolic events) should be referred to CR
3.68 2.68 For 3.68 2.68 For (confirmed)
26 COVID-19 patients requiring percutaneous coronary intervention and/or CIED implant-
ation should be referred to CR
3.50 2.52 For 3.50 2.52 For (confirmed)
27 COVID-19 patients developing pulmonary arterial hypertension should be referred to CR 2.91 2.45 For 2.91 2.45 For (confirmed)
28 COVID-19 patients with prolonged stay in ICU should be referred to CR 0.95 4.04 NC 0.86 3.97 NC
29 COVID-19 patients developing markedly reduced exercise tolerance should be referred
to CR
1.59 3.95 NC 1.50 3.89 NC
30 COVID-19 patients developing cardiovascular complications from therapeutic agents
should be referred to CR
2.41 3.19 NC 2.32 3.14 NC
31 COVID-19 patients with coagulation alterations should be referred to CR -0.09 4.13 NC -0.27 3.98 NC
Consensus rate: 39% Consensus rate: 58%
Comments:
• Patients should not be active COVID-19 (regardless of criteria for referral, CR should take place only if a qualified and recent COVID-19 test is negative)
• In the referral process, a tailored ‘post-COVID’ rehabilitation programme with cardiological support should be always considered as an alternative
• When evaluating appropriate referral to CR for CV patients, it’s important to differentiate between post-acute and chronic conditions also (possibility of delayed











Round 1: Questionnaire development Round 2 Round 3
n Question Mean SD Intermediate
consensus
Mean SD Final
consensusn n n n
• As an alternative approach, referral could be delayed if physical activity and secondary prevention is sufficiently maintained
• The ‘healed’ COVID-19 infection has to be confirmed by the referring institution or referring doctor
• If recent COVID-19 infection, period of 5 weeks after symptom onset should be respected
• When considering CHF patients, priority to class III–IV could be considered
• Need of special considerations for HTX patients: (i) CR only in specialized CR institutions and in close interaction with the transplant heart centre; (ii) CR partici-
pation based on individual decisions, taking into consideration the local situation; (iii) the decision always has to take the local and individual risk into
consideration
• The local implementation of adequate strategies for contagion risk reduction, the potential reduction in the number of CR programmes available and the possible
reduction in the number of health care professionals dedicated to CR (because of COVID ward’s needs, at least in the first phase) might limit the number of
patients that can be enrolled in CR. All these points should prompt the definition of local priorities, trying to enrol the largest possible number of patients
• COVID patients without CV disease seem more suitable for geriatric/pulmonary rehabilitation




In patients without history of COVID there is no need to modify usual policies/recom-
mendations for timing and setting
1.78 3.72 NC 2.30 3.28 NC
33 In patients without history of COVID there is need for fast track (time from referral to
entry <15 days) by CR centres
1.78 3.23 NC 2.13 2.87 NC
34 In patients without history of COVID there is need for delayed track by CR centres -1.70 3.55 NC -2.26 3.25 NC
35 In patients without history of COVID the home environment should be preferred to limit
people’s movements
1.70 2.57 NC 2.09 2.15 NC
36 In patients without history of COVID the outpatient setting should be preferred to avoid
contacts with hospitalized patients and health operators
2.87 2.40 For 2.87 2.40 For (confirmed)
37 Patients with his-
tory of COVID
In COVID-19 patients CR (mainly exercise component) should begin during the acute
phase of the viral disease if the patient is not haemodynamically unstable
-3.10 3.06 Against -3.48 2.44 Against
(confirmed)
38 In COVID-19 patients CR should begin after clinical recovery of pneumonia 1.00 3.86 NC 1.33 3.61 NC
39 In COVID-19 patients CR should begin after radiologic recovery of pneumonia -0.14 3.80 NC -0.38 3.53 NC
40 In COVID-19 patients CR should begin after resolution of COVID-19 induced hypoxia 2.14 3.34 NC 2.29 3.42 NC
41 In COVID-19 patients CR should begin when no more clinical signs 0.38 4.17 NC 0.95 3.77 NC
42 In COVID-19 patients CR should begin after the end of COVID-19 treatment regimen -0.33 3.75 NC -0.24 3.65 NC
43 In COVID-19 patients CR should begin after NIV has been stopped 0.00 4.10 NC 0.33 3.80 NC
44 In COVID-19 patients CR should begin when the P/f value is above 100 -1.50 2.50 NC -1.41 2.45 NC
45 In COVID-19 patients CR should begin when the P/f value is above 200 0.00 2.48 NC 0.47 2.12 NC
46 In COVID-19 patients CR should begin when the P/f value is above 300 1.31 2.50 NC 1.24 2.44 NC
47 In COVID-19 patients the beginning of CR is independent from arterial blood gas
parameters

















Round 1: Questionnaire development Round 2 Round 3
n Question Mean SD Intermediate
consensus
Mean SD Final
consensusn n n n
48 In COVID-19 patients CR should begin after two negative nasopharyngeal specimens for
COVID-19
1.43 3.80 NC 1.52 3.66 NC
49 In COVID-19 patients CR should always comprise a first residential step -0.68 3.17 NC -0.68 3.17 NC
50 In COVID-19 patients CR should always comprise an outpatient step 0.64 3.35 NC 0.64 3.35 NC
51 In COVID-19 patients CR should be always offered as home-rehabilitation or mixed pro-
grammes when appropriate (if available)
2.33 3.14 NC 2.43 3.19 NC
52 In COVID-19 patients enrolled in ambulatory or home-rehabilitation programmes, digital
health tools should be integrated by tracing systems (Gps)
2.18 3.08 NC 2.18 3.08 NC
Consensus rate: 10% Consensus rate: 10%
Comments:
• When considering timing and setting, the clinical severity, local situation (social barriers), and functional limitation need to be strictly considered
• Special attention to false negative nasopharyngeal specimens for COVID-19
• The home environment is dependent on the local COVID-19 situation and national recommendations/laws
• The ‘acute phase’ of COVID-19 has many different clinical manifestations. Patients may be unable to perform physical exercise not because of haemodynamic in-
stability, but because of severe respiratory and/or neuromuscular impairment
• Phase I CR could be considered with specific intervention by trained physiotherapist: (i) ventilation support/weaning with monitoring of clinical conditions
(parameters and signs) and adjustment of oxygen therapy; (ii) disability prevention with mobilization (getting patient out of bed if there is clinical stability), fre-
quent posture changes/continuous rotational therapy, therapeutic postures (early sitting/pronation), and mild active limb exercises; (iii) chest physiotherapy.
Non-productive dry cough should be sedated to avoid fatigue and dyspnoea and bronchial clearance techniques should be carry out for hypersecretive patients
with chronic respiratory diseases, by preferably using disposable devices with self-management.




In patients without history of COVID there is no need to modify usual policies/recom-
mendations for core components delivery
1.87 4.30 NC 2.17 4.01 NC
54 In patients without history of COVID there is need to exclude the presence of COVID-19 2.61 2.87 NC 2.65 2.42 For (new)
55 In patients without history of COVID there is need to modify the core component ‘patient
assessment’
-0.87 4.04 NC -0.78 3.97 NC
56 In patients without history of COVID there is need to modify the core component ‘phys-
ical activity counselling’
-0.95 3.80 NC -0.86 3.72 NC
57 In patients without history of COVID there is need to modify the core component ‘exer-
cise training’
-1.09 4.01 NC -1.18 3.89 NC
58 In patients without history of COVID there is need to modify the core component ‘diet/
nutritional counselling’
-2.91 2.96 NC -2.82 2.92 NC
59 In patients without history of COVID there is need to modify the core component ‘weight
control management’
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60 In patients without history of COVID there is need to modify the core component ‘lipid
management’
-2.77 2.96 NC -2.77 2.96 NC
61 In patients without history of COVID there is need to modify the core component ‘blood
pressure management’
-2.82 2.97 NC -2.82 2.97 NC
62 In patients without history of COVID there is need to modify the core component ‘smok-
ing cessation’
-2.91 2.83 Against -2.91 2.83 Against
(confirmed)
63 In patients without history of COVID there is need to modify the core component ‘psy-
chosocial management’
-1.09 4.10 NC -1.00 4.03 NC
64 In patients without history of COVID there is need to include specific education on
COVID-19
3.00 2.91 For 3.43 2.35 For (confirmed)
65 Patients with his-
tory of COVID
In patients with history of COVID-19 usual core components of CR delivery should be
supplemented with other specific interventions
3.09 3.10 NC 3.45 2.52 For (new)
66 Core component ‘patient evaluation’. Patient evaluation should always comprise respira-
tory impairment and other COVID-19 features
3.57 2.50 For 3.57 2.50 For (confirmed)
67 Core component ‘patient evaluation’. Chest X-ray should always be performed at begin-
ning of the CR programme
1.43 3.63 NC 1.90 3.30 NC
68 Core component ‘patient evaluation’. Nasopharyngeal specimen should always be per-
formed at beginning of the CR programme
1.05 3.97 NC 1.75 3.58 NC
69 Core component ‘patient evaluation’. Nasopharyngeal specimen should always be per-
formed during of the CR programme
-0.80 3.65 NC -0.10 3.63 NC
70 Core component ‘patient evaluation’. Serology for COVID-19 should always be per-
formed at beginning of the CR programme
-0.20 3.78 NC 0.45 3.61 NC
71 Core component ‘patient evaluation’. Serology for COVID-19 should always be per-
formed during the CR programme
-2.45 3.43 NC -2.20 3.41 NC
72 Core component ‘patient evaluation’. Chest CT-scan should always be performed during
the CR programme
-1.85 3.38 NC -1.75 3.31 NC
73 Core component ‘patient evaluation’. Arterial blood gas analysis should always be per-
formed during the CR programme
-0.10 3.78 NC -0.19 3.72 NC
74 Core component ‘patient evaluation’. Direct testing of exercise capacity (CPET preferred)
should always be performed at the start of the CR programme
3.14 2.46 For 3.14 2.46 For (confirmed)
75 Core component ‘patient evaluation’. Indirect testing for exercise capacity should always
be performed at the start of the CR programme
2.38 2.96 NC 2.38 2.96 NC
76 Core component ‘patient evaluation’. Frailty should always be investigated during the CR
programme
3.05 2.80 For 3.05 2.80 For (confirmed)
77 Core component ‘patient evaluation’. History of COVID-19 (symptomatic or asymptom-
atic) among family and caregivers should always be collected
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78 In patients with history of COVID there is need to modify the core component ‘physical
activity counselling’
1.10 4.18 NC 1.48 3.96 NC
79 Core component ‘exercise training’. IMT and/or other respiratory techniques should be
included as normally indicated in the exercise training programme
2.76 3.02 NC 2.76 2.58 For (new)
80 Core component ‘exercise training’. Strength training in COVID-19 should be included as
normally indicated in CR programmes
3.71 1.98 For 3.67 1.96 For (confirmed)
81 Core component ‘exercise training’. Strength training in frail COVID-19 patients should
be included as normally indicated in CR programmes
3.90 1.61 For 4.10 1.34 For (confirmed)
82 Core component ‘exercise training’. Low-to-moderate intense endurance training should
always be executed in COVID-19 patients as normally indicated in CR programmes
2.62 2.65 NC 2.62 2.65 NC
83 Core component ‘exercise training’. High-intensity interval training training should always
be executed by COVID-19 patients as normally indicated in CR programmes
0.24 3.45 NC 0.14 3.42 NC
84 Core component ‘exercise training’. All COVID-19 patients should execute structured ex-
ercise for at least 3 days/week
3.19 2.50 For 3.19 2.50 For (confirmed)
85 Core component ‘exercise training’. All COVID-19 patients should maximize non-struc-
tured physical activity at home on daily basis
3.76 1.87 For 3.76 1.87 For (confirmed)
86 Core component ‘exercise training’. During structured exercise training, cardiac telemetry
is advised to all COVID-19 patients
0.95 3.17 NC 0.76 3.91 NC
87 Core component ‘diet/nutritional counselling’. Nutritional intervention should be always
particularly devoted to malnutrition as a consequence of prolonged immobilization and
ventilatory support
2.95 2.54 For 3.14 2.46 For (confirmed)
88 In patients with history of COVID there is need to modify the core component ‘weight
control management’
-0.71 4.04 NC -0.62 3.96 NC
89 In patients with history of COVID there is need to modify the core component ‘lipid
management’
-0.86 3.99 NC -0.76 3.91 NC
90 In patients with history of COVID there is need to modify the core component ‘blood
pressure management’
-1.33 3.83 NC -1.33 3.72 NC
91 In patients with history of COVID there is need to modify the core component ‘smoking
cessation’
-2.00 3.83 NC -1.91 3.78 NC
92 Core component ‘psychosocial management’. Lifestyle and psychosocial management
should always particularly focused on smoking cessation
3.00 2.94 For 3.27 2.62 For (confirmed)
93 Core component ‘psychosocial management’. Lifestyle and psychosocial management
should always particularly focused on fear of infection
2.73 3.19 NC 2.73 3.19 NC
94 Core component ‘psychosocial management’. Lifestyle and psychosocial management
should always particularly focused on fighting of fake news
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95 Core component ‘psychosocial management’. Lifestyle and psychosocial management
should always particularly focused on caregiver-limiting restrictive measures
2.82 2.44 For 2.82 2.44 For (confirmed)
96 Core component ‘psychosocial management’. Lifestyle and psychosocial management
should always particularly focused on working resume
3.82 1.65 For 3.82 1.65 For (confirmed)
Consensus rate: 32% Consensus rate: 41%
Comments:
• As a general recommendation, in the delivery of core components consider simplified procedures to accelerate turnover
• During counselling, It’s necessary empowering patients with COVID-19 and their caregivers
• Patient assessment needs to strictly evaluate history of contacts and symptoms
• During counselling of physical activity, add information on characteristics of open spaces, distances during exercise and self-protection
• If exercise testing is impossible other tools are needed to evaluate functional capacity
• Avoid face to face supervised exercise training as much as possible (consider video/telephone)
• During exercise training, respiratory techniques should be used with caution
• In some circumstances, more emphasis on physical activity could be given as often exercise training might not be possible
• During nutritional intervention, need to change body composition and improve malnutrition and muscle loss more than weight control
• A specific psychological intervention should be implemented: (i) assessment of patients to identify who survived severe and life-threatening experience and that
are at risk of post-traumatic stress disorder and depression; (ii) psychological/psychotherapeutic programme to reduce emotional distress, to build resilience and
to develop coping strategies
• During smoking cessation intervention, more control of smokers and so-called stoppers by measuring CO%Hb (to prevent further lung damage)
Open question: which are minimal structure-based metrics for CR programmes in the COVID-19 era?
97 There is no need to modify usual policies/recommendations for structure-based metrics -1.71 3.86 NC -1.77 3.78 NC
98 Residential CR facilities should have separated areas for confirmed COVID cases with regard to beds 3.55 2.91 For 3.61 2.86 For (confirmed)
99 Residential CR facilities should have separated areas for confirmed COVID cases with regard to investigation
rooms
2.82 3.22 NC 2.83 3.14 NC
100 Residential CR facilities should have separated areas for confirmed COVID cases with regard to consultation
areas
3.05 3.18 NC 3.04 3.11 NC
101 Residential CR facilities should have separated areas for confirmed COVID cases with regard to exercise
laboratories
2.77 3.21 NC 2.83 3.14 NC
102 Residential CR facilities should have separated areas for confirmed COVID cases with regard to areas for ex-
ercise training
2.68 3.27 NC 2.74 3.21 NC
103 Residential CR facilities should have separated areas for suspected COVID cases with regard to beds 3.45 2.89 For 3.52 2.84 For (confirmed)
104 Residential CR facilities should have separated areas for suspected COVID cases with regard to investigation
rooms
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105 Residential CR facilities should have separated areas for suspected COVID cases with regard to consultation
areas
2.91 3.10 NC 2.91 3.03 NC
106 Residential CR facilities should have separated areas for suspected COVID cases with regard to exercise
laboratories
2.64 3.11 NC 2.70 3.05 NC
107 Residential CR facilities should have separated areas for suspected COVID cases with regard to exercise
training
2.73 3.15 NC 2.78 3.09 NC
108 Residential CR facilities should have separated areas for COVID-free cases with regard to beds 2.67 3.77 NC 2.77 3.72 NC
109 Residential CR facilities should have separated areas for COVID-free cases with regard to investigation rooms 2.24 3.60 NC 2.27 3.52 NC
110 Residential CR facilities should have separated areas for COVID-free cases with regard to consultation areas 2.24 3.60 NC 2.27 3.52 NC
111 Residential CR facilities should have separated areas for COVID-free cases with regard to exercise
laboratories
2.19 3.60 NC 2.27 3.53 NC
112 Residential CR facilities should have separated areas for confirmed COVID-frees with regard to areas for ex-
ercise training
2.33 3.31 NC 2.41 3.25 NC
113 When performing CPET and/or other aerosol-generating testing, approved filters for protecting workers and
other patients from exposure to SARS-CoV-2 should be available
4.55 1.18 For 4.57 1.16 For (confirmed)
114 When performing CPET and/or other aerosol-generating testing, approved FFP-2 masks should be worn to
protect workers and other patients from exposure to SARS-CoV-2 should be available
4.68 0.89 For 4.70 0.88 For (confirmed)
115 Floor space during exercise training is increased from 4 to at least 6 m2 per patient 3.41 3.00 For 3.48 2.95 For (confirmed)
116 In the CR facility PPE for health care workers should be worn 4.17 1.50 For 4.21 1.47 For (confirmed)
117 A CR programme director to ensure proper organization and consistency of activities with national and insti-
tutional rules concerning SARS-CoV-2 infection prevention should be present
4.09 1.44 For 4.13 1.42 For (confirmed)
118 The multidisciplinary team (cardiologist, nurse, exercise specialist, dietitian, psychologist) should be preserved
as much as possible
4.57 1.16 For 4.58 1.14 For (confirmed)
119 All members of the multidisciplinary should receive structured education on COVID-19 pathophysiology, clin-
ical features, treatment, and prevention strategies
4.52 1.31 For 4.54 1.28 For (confirmed)
120 The job description for every profession should be updated with specific COVID-19 oriented features 3.65 2.52 For 3.71 2.48 For (confirmed)
121 The CR facility should provide dedicated operators and structured procedures facilitating contacts between
patients and families in case of lockdown
4.22 1.38 For 4.25 1.36 For (confirmed)
Consensus rate: 44% Consensus rate: 44%
Comments:
• Efforts to maintain residential CR facilities as much as COVID-free as possible
• COVID-19 patients may also be treated separately at the end of the day followed by thorough disinfection
• Recovered COVID-19 patients with negative tests do not need to be separated
• Suspected COVID-19 patients should not participate until confirmed negative tests
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• When an aerosol-generating testing is performed no other patients should be present
• Consider that for frail patients filters may be heavy, due to resistance of this filters on breathing
Open question: which are minimal process-based metrics for CR programmes in the COVID-19 era?
122 There is no need to modify usual policies/recommendations for process-based metrics -1.10 3.91 NC -1.19 3.78 NC
123 The CR unit should provide fast testing and quarantine until test results are available in case of suspected or
confirmed new emerging COVID-19 cases among the referred population
3.32 2.66 For 3.32 2.66 For (confirmed)
124 The suggested duration of CR programmes should be shortened (less than recommended 24 sessions), to in-
crease the absolute number of CR programmes potentially delivered in a time unit
-0.77 3.75 NC -0.68 3.67 NC
125 Patients coming for a CPET or other aerosol-generating procedures are first need to confirm to be COVID-
19 negative
2.45 2.69 NC 2.41 2.65 NC
126 Plan at discharge and structured follow-up should be adapted to different phases of COVID-19 outbreak, in
terms of timeline and diagnostic tools
3.95 1.40 For 3.95 1.40 For (confirmed)
127 CR facilities should offer a continuing help-desk to discharged patients and their caregivers on how to manage
the relationship between COVID-10 and cardiovascular conditions
2.91 2.37 For 2.91 2.37 For (confirmed)
128 CR facilities with structured alternative models for delivering activities (tele-rehabilitation, facilitated home-
based, web-based, supervised community-based, guided by digital health tools, etc.) should integrate the
management of COVID-19 among programme contents
4.09 1.38 For 4.09 1.38 For (confirmed)
129 CR facilities without structured alternative models for delivering activities should implement initial forms of
tele-rehabilitation, with integration of management of COVID-19 among programme contents
3.83 1.70 For 3.96 1.58 For (confirmed)
Consensus rate: 62% Consensus rate: 62%
Comments:
• Increase the rate of hybrid programmes for outpatient CR as much as possible
• Screening for COVID-19 before CPET depends on the region and pre-test probability of COVID-19 positive. If low clinical would be sufficient
• All CR processes need to be adjusted to minimize random infection by COVID-19
• Patients recovered from COVID-19 infection and proved negative COVID-19 test should participate CR according to the accepted CR-indications but addition-
ally should be integrated in multi-centre CR research programmes focusing on COVID-19 patients
Open question: which are quality indicators for CR programmes in the COVID-19 era?
130 There is no need to modify usual quality indicators in non-COVID patients 1.96 3.77 NC 1.87 3.72 NC
131 There is no need to modify usual quality indicators in COVID patients 0.91 3.96 NC 0.74 3.84 NC
132 % patients without history of COVID-19 eligible to CR referred after discharge to CR programme. The target
should be maintained >80% as recommended by the 2020 position statement
2.77 3.16 NC 2.73 2.61 For (new)
133 % patients without history of COVID-19 eligible to CR referred after discharge to CR programme. The target
should be reduced to <80% due to logistic problems during COVID-19 pandemia


















Round 1: Questionnaire development Round 2 Round 3
n Question Mean SD Intermediate
consensus
Mean SD Final
consensusn n n n
134 % patients without history of COVID-19 eligible to CR, enrolled after discharge from COVID-19 units. The
target should be >50% as recommended by the 2020 position statement
2.33 3.35 NC 2.29 3.32 NC
135 % patients without history of COVID-19 eligible to CR, enrolled after discharge from COVID-19 units. The
target should be reduced to <50% due to logistic problems during COVID-19 pandemia
-0.95 3.62 NC -0.85 3.53 NC
136 Patients without history of COVID-19, median waiting time from referral to start of CR. The target should be
14-28 days as recommended by the 2020 position statement
2.29 3.47 NC 2.29 3.47 NC
137 Patients without history of COVID-19, median waiting time from referral to start of CR. The target should be
reduced to <14–28 days, motivated by the necessity to avoid prolonged lack of contacts with health care
providers
-0.33 3.77 NC -0.24 3.67 NC
138 Patients without history of COVID-19, % of CR uptake. The minimal target should be 24 sessions as recom-
mended by the 2020 position statement
3.64 2.38 For 3.73 2.31 For (confirmed)
139 Patients without history of COVID-19, % of CR uptake. The minimal target should be <24 sessions to increase
the absolute number of CR programmes potentially delivered in a time unit
-1.62 4.07 NC -1.71 3.87 NC
140 % patients with history of COVID-19 eligible to CR referred after discharge to CR programme. The target
should be maintained >80% as recommended by the 2020 position statement
2.05 3.73 NC 2.00 3.70 NC
141 % patients with history of COVID-19 eligible to CR referred after discharge to CR programme. The target
should be reduced to <80% due to logistic problems during COVID-19 pandemia
-1.35 3.62 NC -1.25 3.54 NC
142 % patients with history of COVID-19 eligible to CR, enrolled after discharge from COVID-19 units. The target
should be >50% as recommended by the 2020 position statement
1.86 3.55 NC 1.86 3.55 NC
143 % patients with history of COVID-19 eligible to CR, enrolled after discharge from COVID-19 units. The target
should be reduced to <50% due to logistic problems during COVID-19 pandemia
-1.05 3.64 NC -0.95 3.56 NC
144 Patients with history of COVID-19, median waiting time from referral to start of CR. The target should be 14–
28 days as recommended by the 2020 position statement
2.33 3.40 NC 2.33 3.40 NC
145 Patients with history of COVID-19, median waiting time from referral to start of CR. The target should be
reduced to <14–28 days, motivated by the necessity to avoid prolonged lack of contacts with health care
providers
-1.38 3.65 NC -1.29 3.58 NC
146 Patients with history of COVID-19, % of CR uptake. The minimal target should be 24 sessions as recom-
mended by the 2020 position statement
2.64 3.11 NC 2.64 3.11 NC
147 Patients with history of COVID-19, % of CR uptake. The minimal target should be <24 sessions to increase
the absolute number of CR programmes potentially delivered in a time unit
-1.90 3.60 NC -1.95 3.54 NC
148 % of CR drop-out due to de novo COVID-infection. The target should be <10% 3.00 3.13 NC 3.00 3.13 NC
149 % of patients with evaluation of functional capacity by standard exercise testing. The target should be >50% 2.86 3.17 NC 3.00 2.94 For (new)
150 % of patients with improvement of altered respiratory function and gas exchange following completion of CR.
Target >90%































































































and their caregivers on how to manage the relationship between
COVID-19 and CV conditions (2.91 ± 2.37).
Quality indicators
As a result of the Delphi process applied to quality indicators for CR
programmes, no consensus was reached for modulating previously
recommended5 operational standards, in terms of referral rate, taking
charge, minimum number of sessions, programme completion, drop-
out rate, and absolute number of CR programmes in a time unit,
both in patients with and without history of COVID-19. As a new tar-
get specifically introduced to COVID-19 patients presenting altered
respiratory function and/or gas exchange alterations, a significant im-
provement should be reached in more than 90% of patients at the
end of the CR programme (2.82± 2.81).
Impact of COVID-19 experience
Panelists answers were stratified according to home countries with
regard to COVID-19 incidence.9 Consensus was significantly higher
(67% vs. 32%, P < 0.05) among experts coming from countries with
incidence of COVID-19 >_ 400 cases per 100 000 population at the
time of interview (Belgium, Italy, Portugal, Russia, Spain), as compared
to countries with less incidence (Austria, France, Germany, Greece,
The Netherlands, Romania, Switzerland). Experts from high inci-
dence countries were more oriented towards the possibility of
delayed referral to CR for stable chronic cardiac patients, the need of
complete resolution of major COVID-19 symptoms before entering
CR facilities, and the consideration of simplified procedures to accel-
erate patients turnover (see comments in Table 1).
Discussion
Shortly after the beginning of the COVID-19 outbreak, the problem
on how to ensure proper delivery of CR activities across Europe has
surfaced. Several national institutions adopted formal positions on
this topic,10–14 and the EAPC itself provided fast general recommen-
dations,15 followed by a structured call to action for cardiac telereha-
bilitation as a tool to help CV patients not able to visit outpatient CR
clinics regularly.16 Given the absence of evidence-based guidelines on
how CR facilities should orient organizational aspects and performan-
ces during the COVID-19 crisis in Europe, expert consensus might
supply clinically useful guidance. This Delphi process enrolled EAPC
experts also from nations most affected by COVID-19 and adopted a
pragmatic approach aimed to identify major drivers of CR interven-
tion (referral, timing, setting, core components, institutional structure
and process, and quality indicators) to be customized to the new era.
As main results, panelists oriented consensus towards maintaining
usual activities on traditional patient groups referred to CR: in ab-
sence of COVID-19, CR may follow usual setting (with preference
for ambulatory), timing, and core components of intervention, while
programmes including COVID-19 patients should pay special atten-
tion to respiratory impairment, psychosocial management, and care-
givers, also by encouraging multicomponent home rehabilitation.
This position aimed at avoiding significant downgrading of CR
intervention was based on adverse consequences of depriving large
portion of CV patients of structured secondary prevention, with a


















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































and progressive disability in the next future.17 Panelists also suggested
to consider COVID-19 patients as a referral group to CR per se
when the viral disease has been complicated by acute CV events, and
to strongly cooperate with pulmonologists. In an economic perspec-
tive, over the primary mission to care and promote health, this ap-
proach might lead to further opportunities to CR facilities, and
generally speaking, the discipline of cardiac prevention and rehabilita-
tion might be electively involved in the development of specific rec-
ommendations for multicomponent rehabilitation in COVID-19,
which should not be confined into the pulmonary setting.
With regard to core components of intervention in the ‘cardiac-
COVID’ patient, we do not have at the moment intervention trials or
cohort studies able to identify the proper strategy in the proper pa-
tient, and the expected outcome. For this reason, most of suggested
adaptations to usual recommendations4 are quite anecdotal and
based on real-life practice. Interestingly, after the frantic search for
the best pharmacologic treatment of COVID-19, this expert consen-
sus is highly regarded on psychosocial support to patients and their
relatives/caregivers, as part of really multicomponent CR pro-
grammes,18 to better meet growing population’s needs after the
emergency phase. An important consensus was also reached on the
need for continuing CPET activities, in line with other expert opin-
ions on this topic,19 to ensure a properly test-guided and individual-
ized training programme.
In this revised definition of structure- and process-based metrics
of CR programmes, cardiac telerehabilitation has been naturally
invoked as a support of CR in times of temporary closure of centre-
based CR programmes, limited centre resources, and restricted pa-
tient travel.16 Anyway, rather than a temporary alternative, cardiac
telerehabilitation should be considered as a necessary provision of
modern CR activities, and the sudden increased experience with
digital communication by patients and health care providers during
this pandemic could be properly exploited and addressed.
As a major strength, this document provides a structured answer
to an urgent need by CR facilities, to be supported in the definition of
priorities and allocation of human and technological resources still
available, while at the same time several national health systems are
suffering and large case studies are still in-progress.
Several limitations of this expert consensus need to be taken into
consideration. First, the heterogeneity of expert positions according
to different countries and different pandemic phases, which makes it
difficult and probably impractical to pursue a globalizing point of
view. As a consequence, due to different epidemic spreading among
regions, recommendations need to be carefully adapted not only at a
country level, but often at a regional and local level, and this is in line
with previous recommendations to CR facilities to be flexible and
creative,16 by constantly monitoring the situation and being prepared
to change the framework. Second, the limited rate of consensus
obtained (about 40% of all proposed statements), which may reflect
different attitudes and concepts regarding the role of CR during the
COVID-19 crisis, probably linked to different time courses of epi-
demic across Europe. As an example, changes in opinion of panelists
between round 2 and 3 might also be due to an adaptation, better
understanding or eventually to a personal experience change during
the ongoing pandemic/referrals, even in a short time. In this view,
there is need for continuing education on COVID-19 disease in the
learning path of CR teams. Finally, other methodological limitations
such as the ex ante selection of a consensus method based on mean
and SD (without preliminary testing for normal distribution of grading
results), and the absence of a structured tool to quote statements for
relevance, need also to be considered.
In conclusion, even in COVID-19 times CR retains its import-
ance for the care of CV patients, and now more than ever there is
need for creativity and innovation in this discipline. In the current
climate, telerehabilitation has been systematically invoked as the
best solution for continuing CR activities nevertheless, while es-
sential, it still need specific optimization and cannot be provided to
all patients. For this reason, as long as with the spreading of the
pandemic, the CR European network is called upon to reconsider
all operational aspects of intervention and to prepare all health
operators as well.
Conflict of interest: none declared.
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